Drugs / Platelet-Rich Plasma-Fibrin Glue
Platelet-Rich Plasma-Fibrin Glue
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT05850611 | Apr → Aug 2023 | ulcer of lower limbs | Mashhad University of Medical Sciences | Unknown | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT05983302 | Aug 2023 → Jan 2024 overdue | — | Mashhad University of Medical Sciences | Active not recruiting | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04315909 Background | Aug 2019 → Jun 2020 | ulcer of lower limbs | Mashhad University of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Platelet-Rich Plasma-Fibrin Glue | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05850611 ↗ |
| Known as | PRP-FG | “The current study assesses the effects of platelet-rich plasma-fibrin glue (PRP-FG) dressing along with oral vitamin E and C on wound healing and biochemical markers in...” PMID 33646060 ↗ Apr 2021 |
| Known as | PRP-Fibrin Glue | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04315909 ↗ |
| Route | Topical | “PRP-FG dressing” NCT05850611 ↗ |